USA 109 , 1359013595 (2012)
Genetic mutation or deficiency of PARK7/DJ-1 disrupts dopamine metabolism, induces ROS accumulation, and impairs mitochondrial function in neuronal cells
no NDA has been filed for monotherapy at this time
Standard IGF-1 IGF-1 LR3's reduced IGFBP binding makes it the preferred choice for in vitro research where consistent, predictable growth factor exposure is required
Youre supporting a molecule the body already depends on, one whose production tends to fall with age, chronic stress, and certain health conditions
Injection Site Subcutaneous injection near the injury site when practical (e.g., near a knee or shoulder injury), or in the abdomen